Young patients with fertility needs should be closely monitored when using progestogens in conjunction with conservative treatments.
Patients with endometrial cancer who do not need to have children should take special care to avoid stimulation of exogenous estrogen after surgical resection.
Progestogens play a crucial role in the treatment of advanced or recurrent endometrial cancer.
When selecting chemotherapy drugs, the patient's specific circumstances, including physical condition, liver and kidney function, should be carefully considered to develop a personalized chemotherapy plan.
Emerging treatments like targeted therapy and immunotherapy are viable options for patients with metastatic or recurrent endometrial cancer.